Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ: IMDX · Real-Time Price · USD
5.24
-0.34 (-6.09%)
At close: Dec 5, 2025, 4:00 PM EST
5.00
-0.24 (-4.58%)
After-hours: Dec 5, 2025, 5:06 PM EST
IMDX Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for IMDX stock has a target of 9.00, which predicts a 71.76% increase from the current stock price of 5.24.
Price Target: $9.00 (+71.76%)
Analyst Consensus: Strong Buy
Analyst Ratings
According to 1 stock analyst, the rating for IMDX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|
| Strong Buy | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 |
| Total | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $4.25 → $9 | Strong Buy | Maintains | $4.25 → $9 | +71.76% | Nov 11, 2025 |
| Needham | Needham | Strong Buy Reiterates $4.25 | Strong Buy | Reiterates | $4.25 | -18.89% | Aug 18, 2025 |
Financial Forecast
Revenue This Year
3.28M
from 1.88M
Increased by 74.53%
Revenue Next Year
3.65M
from 3.28M
Increased by 11.24%
EPS This Year
-1.17
from -4.66
EPS Next Year
-0.86
from -1.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.5M | 5.4M | |
| Avg | 3.3M | 3.7M | |
| Low | 3.1M | 1.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 84.2% | 63.1% | |
| Avg | 74.5% | 11.2% | |
| Low | 65.4% | -66.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.16 | -0.78 | |
| Avg | -1.17 | -0.86 | |
| Low | -1.20 | -0.98 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.